Preventing Illegal Laboratories and Protecting Public Health Act of 2025

Increased Oversight of Dangerous Pathogens: The requirement for covered distributors to maintain a logbook of the sale, lease, loan, or transfer of highly pathogenic agents ensures better tracking of dangerous materials (Section 2(a) and 2(c)).

Enhanced Security via Identification Requirements: By requiring purchasers to present a government-issued photo identification card and verify their information, the bill adds a layer of verification for those acquiring dangerous agents (Section 2(c)(3)).

Improved Laboratory Safety Standards: The mandate for a single Federal entity to conduct strategic evaluations of high-containment laboratories aims to assess their capacity to meet national biosafety and biosecurity goals (Section 3(a) and 3(b)).

Better Coordination for Local Officials: The creation of the Public Health Biosafety and Biosecurity Team provides a single point of contact for State, local, Tribal, and territorial agencies regarding laboratory biosafety and biosecurity issues (Section 3(d)).

Information Accessibility for Officials: The feasibility study for a database could allow Federal, State, local, Tribal, and territorial officials to access information regarding high-containment laboratory owners, addresses, and legal violations (Section 3(e)).

Legal Risks for Purchasers: The bill notes that entering false statements or misrepresentations in the required logbook may subject purchasers to criminal penalties, including fines and imprisonment (Section 2(c)(4)).

Compliance Burdens for Distributors: Covered distributors are required to maintain detailed electronic logbooks for at least three years and must ensure successor entities assume responsibility for these records if ownership changes (Section 2(c)(5)).

Increased Regulation of High-Containment Laboratories: The evaluation process includes assessing the risks associated with expanding the number and facilities of high-containment laboratories (Section 3(b)).